It has been shown Tregs (Foxp3+, CD3+, CD4+, CD25high, CD127low) are significantly decreased in severe SARS-CoV-2 patients, suggesting a possible role in hyper-inflammatory responses in COVID-19 pathogenesis [161,162,163]. The gene discussed is CD4; the disease is COVID-19.